Li YC - Search Results

1

MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation.

Liang YK, Zeng D, Xiao YS, Wu Y, Ouyang YX, Chen M, Li YC, Lin HY, Wei XL, Zhang YQ, Kruyt FA, Zhang GJ. Liang YK, et al. Among authors: li yc. Cancer Lett. 2017 Feb 1;386:65-76. doi: 10.1016/j.canlet.2016.11.004. Epub 2016 Nov 9. Cancer Lett. 2017. PMID: 27838413 Free article.

2

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin.

Liang S, Peng X, Li X, Yang P, Xie L, Li Y, Du C, Zhang G. Liang S, et al. Oncotarget. 2015 Jan 20;6(2):1020-30. doi: 10.18632/oncotarget.2741. Oncotarget. 2015. PMID: 25544759 Free PMC article.

3

Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.

Chen CF, Dou XW, Liang YK, Lin HY, Bai JW, Zhang XX, Wei XL, Li YC, Zhang GJ. Chen CF, et al. Among authors: li yc. Cell Cycle. 2016;15(3):432-40. doi: 10.1080/15384101.2015.1127474. Cell Cycle. 2016. PMID: 26694515 Free PMC article.

4

Analysis of Epithelial-Mesenchymal Transition Induced by Overexpression of Twist.

Bai JW, Zhang YQ, Li YC, Zhang GJ. Bai JW, et al. Among authors: li yc. Methods Mol Biol. 2017;1652:259-274. doi: 10.1007/978-1-4939-7219-7_17. Methods Mol Biol. 2017. PMID: 28791647

5

Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α.

Dou XW, Liang YK, Lin HY, Wei XL, Zhang YQ, Bai JW, Chen CF, Chen M, Du CW, Li YC, Tian J, Man K, Zhang GJ. Dou XW, et al. Among authors: li yc. Theranostics. 2017 Sep 20;7(16):4041-4056. doi: 10.7150/thno.19989. eCollection 2017. Theranostics. 2017. PMID: 29109797 Free PMC article.

6

Cell cycle regulation and anticancer drug discovery.

Bai J, Li Y, Zhang G. Bai J, et al. Cancer Biol Med. 2017 Nov;14(4):348-362. doi: 10.20892/j.issn.2095-3941.2017.0033. Cancer Biol Med. 2017. PMID: 29372101 Free PMC article.

7

Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression.

Lin HY, Liang YK, Dou XW, Chen CF, Wei XL, Zeng D, Bai JW, Guo YX, Lin FF, Huang WH, Du CW, Li YC, Chen M, Zhang GJ. Lin HY, et al. Among authors: li yc. Oncogenesis. 2018 Aug 13;7(8):59. doi: 10.1038/s41389-018-0069-z. Oncogenesis. 2018. PMID: 30100605 Free PMC article.

8

Long noncoding RNA ATB promotes the epithelial-mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer.

Li RH, Chen M, Liu J, Shao CC, Guo CP, Wei XL, Li YC, Huang WH, Zhang GJ. Li RH, et al. Among authors: li yc. Cell Death Dis. 2018 Dec 5;9(12):1171. doi: 10.1038/s41419-018-1210-9. Cell Death Dis. 2018. PMID: 30518916 Free PMC article.

9

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin.

Liang S, Peng X, Li X, Yang P, Xie L, Li Y, Du C, Zhang G. Liang S, et al. Oncotarget. 2022 Apr 1;13:583-584. doi: 10.18632/oncotarget.28109. eCollection 2022. Oncotarget. 2022. PMID: 35391718 Free PMC article.

10

Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells.

Chen W, Zhang Y, Li R, Huang W, Wei X, Zeng D, Liang Y, Zeng Y, Chen M, Zhang L, Gao W, Zhu Y, Li Y, Zhang G. Chen W, et al. Cells. 2022 Sep 14;11(18):2872. doi: 10.3390/cells11182872. Cells. 2022. PMID: 36139447 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,724 results

Search Page

Filters